J. B. Remedies Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 6.76 M
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.23 Cr
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth -3.24%
- Profit Growth 10.01%
- Ebitda -15.10%
- Net Worth 2.60%
- Total Assets -4.84%
About J. B. Remedies
J. B. Remedies Private Limited (JBRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 May 2007 and has a history of 17 years and eight months. Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 6.76 M.
The company currently has active open charges totaling ₹7.23 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shreevats Goel and Arun Kumar serve as directors at the Company.
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239UR2007PTC032413
- Company No.
032413
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at J. B. Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreevats Goel  | Director | 29-May-2007 | Current |
| Arun Kumar | Director | Current |
Financial Performance of J. B. Remedies.
J. B. Remedies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.24% decrease. The company also saw a substantial improvement in profitability, with a 10.01% increase in profit. The company's net worth moved up by a moderate rise of 2.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J. B. Remedies?
In 2023, J. B. Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹72.26 M
₹20.00 M
Charges Breakdown by Lending Institutions
- Others : 7.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2023 | Others | ₹4.00 M | Open |
| 29 Nov 2021 | Others | ₹1.47 Cr | Open |
| 18 May 2020 | Others | ₹3.20 M | Open |
| 29 Apr 2020 | Others | ₹1.20 Cr | Open |
| 20 Mar 2017 | Others | ₹4.00 M | Open |
How Many Employees Work at J. B. Remedies?
J. B. Remedies has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J. B. Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J. B. Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
